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Abstract 
Background: Recent researches pointed to executive dysfunction as a potential early predictor 
of the progression Mild Cognitive Impairment (MCI)  dementia in clinical 
syndrome (ACS). Such cognitive impairments account for functional impairments in 
instrumental activities of daily living (IADL). Objective: The present study analyse the 
contributions of executive functions to predict MCI  dementia progression in ACS. Methods: 
We assessed 145 participants, 51 cognitively unimpaired and 94 MCI. The latter were divided 
using the traditional, memory-based MCI classification (single domain amnestic, multidomain 
amnestic and non-amnestic). Eight tests assessing executive functions were administered at 
baseline and at 1-year follow-up, together with cognitive screening tools and IADL measures. 
MCI patients were reclassified based on the outcomes from a K-mean cluster analysis which 
identified three groups. A simple lineal regression model was used to examine whether the 
classification based on executive functioning could more accurately predict progression to 
dementia a year later. Results: Clusters based on executive function deficits explained a 
significant proportion of the variance linked to MCI  dementia conversion, even after 
controlling for the severity of MCI at baseline (F(1, 68) = 116.25, p=0.000, R2=0.63). Classical 
memory-based MCI classification failed to predict such a conversion (F(1, 68) = 5.09, p=0.955, 
R2=0.07). Switching, categories generation and planning were the executive functions that best 
distinguished between MCI converters and stable. Conclusion: MCI with a dysexecutive 
phenotype significantly predicts conversion to dementia in ACS a year later. Switching abilities 
and verbal fluency (categories) must be evaluated in MCI patients to assess risk of future 
dementia. 
Keywords: activities of daily living, Alzheimer Disease, cognitive dysfunction, 
executive function, longitudinal studies.  
Introduction 
Mild Cognitive Impairment (MCI) is understood as a risk state for dementia [1, 2, 3, 4, 5]. 
MCI patients could progress to dementia (from 4 to 15% in clinical setting [6] and from 
4 to as high as 17% in community-based studies [7]), could remain stable or could even 
revert to a normal cognition [4, 8, 9, 10, 11, 12]. It is a current target to identify those who 
hold a high risk of progressing to dementia to provide interventions that can prevent or 
slow further cognitive decline.  
Memory is the cognitive domain that has been more widely studied in the early stages 
of Alzheimer´s clinical syndrome (ACS).  decline follows a trajectory similar 
to that seen in general cognitive functioning [5, 8]. In addition, memory decline could 
predict the transit from normal cognitive functioning to MCI and from MCI to dementia 
in ACS [13, 14, 15, 16]. However, memory is not the only cognitive function that decline 
early in Alzheimer´s [5, 8, 17]. This has led to investigate whether the combined 
assessment of episodic memory and other cognitive domains, such as executive 
functioning, could increase sensitivity and reliability [9, 12, 18, 19, 20]. Such studies have 
focused on executive dysfunction as an early potential predictor of the progression to 
dementia stage in ACS due to their relation to pathological aging and dysfunctions in 
activities of daily living whether basic (ADL) [2, 21, 22] or instrumental (IADL) [23]. 
Executive functions such as inhibition, planning or decision making, which are impaired 
in MCI, are independence in their IADL/ADL [5, 10, 13, 24]. 
Therefore, some researches have focused on executive dysfunction as a subtype of MCI 
 dysexecutive MCI. Using screening tests for ACS, Mez et al. [21] noticed that a 
dysexecutive MCI subgroup declined faster than an amnestic group. They suggested 
that such groups follow different disease trajectories [5, 20]. Kuzmickienè & Kaubrys [17] 
confirmed that executive disorders could have worse effects on ADL and quality of life 
of patients than memory disorders and explained that the main feature of dysexecutive 
function is cognitive slowing. 
The evidence above supports the need of further longitudinal assessments to ascertain if 
impaired executive functions could be an early predictor of progression from MCI to 
dementia in the ACS. Supporting this notion is the subtype of MCI that presents with 
memory and other cognitive impairments (multidomain amnesic MCI - maMCI), being 
executive functions those more commonly affected [9, 25]. Some studies pointed out that 
maMCI exhibits the fastest progression to dementia in ACS in longitudinal studies [4, 11, 
12]. Notwithstanding the evidence remains mixed with some studies showing that 
dysexecutive MCI holds a higher risk to progress to dementia in ACS [2], while others 
concluded that amnestic and multidomain-amnestic MCI had a similar risk of 
conversion to that dementia [26].  
It is acknowledged that MCI is a heterogeneous condition [3, 12, 14] which needs to be 
carefully considered when assessing risk of dementia in the ACS. Recent consensus 
papers try to address this by encouraging the use of biomarkers [27, 28, 29]. However, those 
papers acknowledge that while such methodologies become more widely available, 
better characterization of neuropsychological profiles will be necessary to enhance the 
reliability of clinical criteria [30]. 
Taken together the evidence discussed above and recent calls for better forms of 
assessment, the present study focuses on dysexecutive MCI as a promising phenotype of 
MCI linked to dementia risk in the ACS. To this aim, we contrasted the risk of 
developing dementia in the ACS [29] depending on whether MCI patients were grouped 
based on the classical memory-based deficits (amnesic MCI, multidomain amnesic MCI 
and non-amnesic MCI) or the dysexecutive profile. Such an approach, which explicitly 
compares the predictive value of the traditional MCI classification with that of other 
approaches aimed at enhancing cognitive phenotypes of risk among MCI patients, has 
not reported in the relevant literature to date. We hypothesized that the dysexecutive 
profile would predict MCI to dementia progression better than the traditional MCI 
classification. From this perspective, our study focuses on distilling the precise 
contribution of executive function impairments found in maMCI to dementia 
progression in the ACS. 
Methods 
Participants 
A total of 148 participants took part in this research. Three of them were excluded since 
their cognitive decline was at a more advanced stage than MCI [29], confirmed by a 
neurologist. 145 participants (108 females and 37 males) were included and divided in 
two groups, cognitively unimpaired (n = 51) and MCI patients (n = 94) [29]. They 
completed two extensive neuropsychological assessments one year apart. Participants 
were recruited from different hospitals and senior centres from Madrid. In accordance 
with the Declaration of Helsinki (1991), participants were fully informed about the aims 
of the study and they provided informed consent for longitudinal assessment prior to 
their enrolment. Participants did not report significant medical, neurological, vascular or 
psychiatric conditions, history of alcohol abuse or sensory impairment.  
The cognitively unimpaired (CU) group was formed by elderly adults with no cognitive 
complaints and preserved neuropsychological and functional abilities as informed by 
the Mini-Mental State Examination (MMSE > 26 [31, 32]
Cognitive Examination Revised, ACE-R [33]) and Lawton & Brody IADL (Lawton & 
Brody = 8 for women and Lawton & Brody > 5 for men [34]). 
Elderly adults entered the study as MCI patients if they have informant-corroborated 
subjective complaints of declining memory functioning, impaired performance on 
general cognitive scales (MMSE scores between 24 and 26 [31, 32,33]), Verbal Learning 
Test España-Complutense or TAVEC (TAVEC scores 1.5 SD below age norms [35]) and 
Rey Osterrieth Complex Figure test (test score 1.5 SD below age norms [36]); mildly 
impaired IADL (Lawton & Brody < 8 for women and Lawton & Brody < 5 for men 
[34]), and a Clinical Dementia Rating (CDR) between 0 and 0.5 [37]. MCI patients did not 
differ from healthy controls on the Geriatric Depression Scale (GDS < 5 [38]). 
MCI patients were subsequently classified on the basis of the traditional criteria [1, 39] in: 
Single Domain Amnestic MCI (a-MCI) if participants have objective memory 
impairment (defined as a test score 1.5 SD below age norms on the TAVEC Immediate 
recall (Spanish adaptation of California Verbal Learning Test), TAVEC Delayed  recall 
and Immediate recall of the Figure of Rey); Multidomain Amnestic MCI (ma-MCI) if 
participants have objective memory impairment (defined as a test score 1.5 SD below 
age norms on the TAVEC Delayed and Immediate recall and Immediate recall of the 
Figure of Rey) plus other cognitive domain deficits (language, executive functions, 
visuo-spatial ability, attention  measured as explains in assessment below); and Non-
amnestic MCI (na-MCI) if participants have no objective memory impairment (defined 
by a test score equal or above 1.5 SD from age norms on the TAVEC Immediate and 
delayed recall and the Immediate recall of the Figure of Rey); and a test score below 1.5 
SD from the norms on other cognitive domains such as language, executive functions or 
visuo-spatial ability. Tests assessing these domains were specified below. In addition, 
classification of MCI was contingent upon the lack of evidence of dementia as informed 
by a MMSE < 24 and lack of IADL impairments which precluded independent living. 
In the non-amnesic MCI sample we found that 2 patients presented with language 
deficits (2.13% of MCI sample), 8 with executive dysfunction (8.51%), 7 with 
executive dysfunction and language deficits (7.45%) and 1 with executive dysfunction, 
language deficits, and visuoperceptual impairments (1.06%). Moreover, 10 of the 18 
non-amnestic MCI patients were of single domain and 8 were multiple domain non-
amnestic MCI. 
Diagnosis was confirmed by an external clinical auditor composed by neurologists who 
analysed blind data.  
Assessment 
148 participants were assessed at baseline in two sessions that took 90 minutes, and 108 
of them were followed up 12 (± 1) months after. Attrition was 27.03% and it was due to 
patients  (Figure 1). 
Our neuropsychological battery included screening test: MMSE (obtained from 
tive Examination Revised, ACE-R [33]), functional and clinical 
scales: Lawton & Brody [34], ECOG Scale [40], Blessed Scale [41], CDR [37] and The 
Neuropsychiatric Inventory  Questionnaire (NPI-Q) [42]. 
The assessment also comprised tests that measure cognitive domains such as memory: 
Verbal Learning Test España-Complutense (TAVEC [35]), Rey Osterrieth Complex 
Figure test [36]; language: Boston Naming Test (short format) [43]; visuo-spatial ability: 
Rey Osterrieth Complex Figure test; attention: digits (WAIS-IV [44]) and Stroop Test 
[45]; and executive functions from WAIS-IV: Similarities, Arithmetic, Reverse Digits, 
and Letters and Numbers, Trail-Making Test (TMT [46]); Stroop Test; Verbal Fluency  
phonemic and categories [47]; and Zoo Map included in Behavioural Assessment of 
Dysexecutive Syndrome (BADS [48]) where final profile score was taken into account. 
Executive function components were analysed: planning, categorization, verbal fluency, 
inhibition and switching [49, 50]. 
Statistical Analysis 
Comparisons between groups for demographic characteristics, clinical questionnaires, 
clinical neuropsychological tests and executive function tests were performed using 
parametric t test and cohen-d for calculating effect size.  A multiple comparison using 
ANCOVA analysis was performed to compare MCI groups, using age as covariate. 
These comparisons between groups were followed up by Bonferroni corrected post-hoc 
tests. 
K-Mean cluster analysis was carried out to identify clusters of MCI patients using 
executive function variables (TMT B-A, Verbal Fluency phonemic - FAS, Verbal 
Fluency Semantic  Categories (Animals, Fruits, Cookware and clothes), Stroop Test, 
Zoo Test, Similarities, Arithmetics, Reverse Digits and Letters and Numbers from 
WAIS). We decided to build three groups of dysexecutive MCI to follow the traditional 
MCI classification (aMCI, maMCI and naMCI). We were interested in exploring the 
mapping between the new executive function and the traditional memory classification. 
Four iterations were necessary to perform the analysis. A multiple comparison using 
ANCOVA analysis was then performed to compare clusters using age as covariate. 
These comparisons between groups were followed up by Bonferroni corrected post-hoc 
tests. Z-scores were obtained and groups and clusters analysis were performed in order 
to corroborate significant differences among MCI and control groups first, and among 
clusters and controls then. 
In order to compare which classification better accounted for progression to dementia in 
the ACS, linear regression analysis was performed using conversion to dementia in 
ACS as the dependent variable and MCI groups or clusters as predictors. Then, stepwise 
regression analyses were performed using classical / dysexecutive MCI classification 
and MMSE as covariate to controls for the effect of baseline disease severity. An 
additional stepwise regression analysis was carried out to assess the potential influences 
of other neuropsychological impairments (i.e., language) to dysexecutive profiles in 
MCI patients. The rationale for such an analysis was that the neuropsychological tasks 
used in our assessment protocol also tax language functions. It is therefore relevant to 
disentangle the contribution of such cognitive domains to profiles of risk of dementia 
among MCI patients.  
 
Results 
Classical MCI groups 
MCI groups showed significantly worse performance than CU at baseline and at one-
year follow-up on most clinical and neuropsychological measures (Table 1). Significant 
differences in CU and MCI were not found a year later, which means that groups remain 
stable over a year of follow up assessment (Table 2). 
Among MCI participants, 26 were identified as a-MCI, 50 as ma-MCI and 18 as na-
MCI. There were no significant differences between groups in education (F(3, 149) = 
2.55, p=0.06). As age was found to be significantly different between groups, it entered 
ANCOVA as a covariable. Ma-MCI group was the one with worse performance on 
most of the neuropsychological tests (Table 3 and Table 4). Moreover, on inspection of 
z-scores, maMCI was the group with more significant differences from CU both at 
baseline and at one year follow-up (Table 5). In addition, NPI-Q data revealed 
significant difference between MCI groups neither at baseline (p=0.172) nor at 1 year 
follow-up assessment (p=0.063). 
 
MCI Groups from cluster analysis 
The analysis identified 3 clusters of MCI patients. As it is shown in Figure 2, Cluster 1 
(N=56) has the most heterogeneous mixture of classical MCI groups, Cluster 2 (N=28) 
includes mainly multidomain and non-amnestic MCI (memory is not the only cognitive 
domain impaired or it is not impaired, respectively) and Cluster 3 (N=10) includes only 
multidomain amnestic MCI. The distance between cluster 1 and cluster 3 was the 
largest (d = 425.53), between cluster 1 and cluster 2 was the shortest (d = 192.91), and 
between clusters 2 and 3 was in the middle (d = 232.94), thus suggesting that cluster 3 
was the most independent whereas cluster 1 and 2 shared characteristics. 
Analysis of clinical phenotypes of patients falling within these clusters was carried out. 
As age was found to be significantly different between clusters, it entered ANCOVA as 
a covariable. 
Significant differences were found when comparing the three clusters and these against 
the CU group (Table 6). As suggested by the cluster analysis, cluster 3 proved to be the 
most distinct, with the largest number of significant differences resulting from 
comparisons with cluster 1, followed by comparisons with cluster 2. These cluster also 
showed a large number of significant contrasts when compared to CU group (Table 7).  
 
Analysis of dementia conversion  
Our longitudinal data confirmed that only ma-MCI patients progressed to dementia in 
the ACS a year later (10/48 participants) when classical memory-based MCI 
classification was considered. Our cluster analysis identifying dysexecutive MCI 
revealed that progression to dementia in ACS was only observed in patients from cluster 
3 (10/10 participants) which all happened to be in the ma-MCI category (Table 8). 
These results suggest that progressing to dementia in ACS is more likely if in the ma-
MCI category, and based on cluster analysis this progression is contingent upon 
impairments in the domain of executive function with 100% of patients from cluster 3 
(purely ma-MCI) progressing to dementia a year later (Table 8). 
When compared MCI converters versus MCI stable (Table 9) across the core executive 
functions, we found that TMT B-A and Verbal Fluency - Categories were those with the 
largest discrepancies. These were followed by the Zoo test, Phonemic Fluency (FAS), 
Letters and Number, and Similarities. 
Moreover, when executive function components were analysed to find which of them 
was more accurate predicting conversion from MCI to dementia in ACS (table 10), 
simple and stepwise linear regression models showed that TMTB-A and Verbal Fluency 
- Categories explained together 45% of variance associated to MCI-dementia 
progression in ACS (F(2, 67) = 27.49, p=0.000, R2=0.45). 
The simple linear regression model (Table 11) revealed that the classical classification 
of MCI as a predictor did not account for a significant proportion variance when 
considering progression to dementia in ACS as the dependent variable (F(1, 68) = 0.08, 
p=0.776, R2=0.00). However, the dysexecutive classification of MCI resulting from 
cluster analysis entering as a predictor and progression to dementia in ACS as the 
dependent variable did (F(1, 68) = 41.92, p<.001, R2=0.38). A stepwise regression 
model covariating for disease severity using the MMSE and assessing the dysexecutive 
classification of MCI as a predictor and progression to dementia in ACS as the 
dependent variable yielded significant results after excluding the MMSE (F(1, 68) = 
116.25, p<.001,  R2=0.63). When the same model was run with the classical MCI 
classification only the MMSE accounted for a significant proportion of variance across 
MCI converters and non-converters with the classical MCI classification excluded (F(1, 
68) = 5.09, p=0.955, R2=0.07). This analysis was also run using ACE-R and CDR 
instead of MMSE and similar results were found. 
The additional stepwise regression analysis (Table 12) ruled out the potential influences 
of language impairments to the dysexecutive MCI phenotype that best predicted risks of 
dementia conversion. The model that significantly accounted for conversion to dementia 
retained the dysexecutive subtypes classification and Category fluency as best 
predictors (F(2,67)=62.93, p<0.001, R2=0.64) and excluded the Boston Test and 
Phonemic Fluency. These results support the notion that the presence of dysexecutive 
impairments in the maMCI profile increases risk to dementia independently of language 
impairments. 
 
Discussion 
The present study was set out to investigate whether the classical MCI classification and 
one based on a dysexecutive profile could equally predict risk of developing dementia 
in the ACS. In line with our hypotheses, we focused on the amnestic MCI phenotype as 
this is the MCI subtype that has been linked to the highest risk of progression to 
dementia in the ACS. We found a rate of conversion to dementia of 10.64% in our MCI 
patients, which is rate consistent with previous studies [6, 59]. Our results confirm that 
ma-MCI is the classical MCI group which is more likely to progress to dementia in the 
ACS a year later [4, 11], since there were neither single domain amnestic MCI nor non-
amnestic MCI patients that progressed to dementia (Table 8).  Therefore, ma-MCI was 
the MCI group with the highest rate of conversion to dementia in the ACS and 
executive functions was the cognitive domain that added most to the 
neuropsychological phenotype of this MCI group [9, 25]. Therefore, we examined 
executive functions as a possible predictor of MCI to dementia progression in ACS. To 
this aim, we needed a MCI classification which was not solely based on memory 
impairments but would consider executive functions (dysexecutive MCI), as other 
researcher groups have previously done [2, 5, 21, 22, 23]. We found that dysexecutive MCI 
classification significantly predicted the probability of developing dementia in the ACS 
a year later. This result is consistent with those that previously pointed to executive 
functions as the cognitive domain more reliably linked to dementia in ACS in MCI 
patients [9, 10, 19, 20, 23, 51]. In addition, traditional memory-based MCI classification did 
not significantly predict MCI to dementia progression in ACS. This finding is consistent 
with other studies that suggested that memory-based classifications may not provide the 
best framework to identify and predict dementia in in the symptomatic stages of the 
ACS [8, 12]. Our results show that dysexecutive MCI classification is more accurate than 
memory-based classification to predict MCI to dementia conversion in ACS. Of note, 
we observed that the dysexecutive MCI classification predicted 63% of the variance of 
the conversion, even when controlling for severity of the disease at baseline. Thus, the 
predictive value of executive functions cannot be attributed to disease severity as it has 
been often claimed for ma-MCI [2, 4, 9, 11]. Furthermore, as we did not find significant 
neuropsychiatric disturbances in our MCI groups, we feel confident to suggest that 
a key feature of the MCI phenotype linked to risk to 
progression to dementia in the ACS.  
Moreover, we showed that switching and categories verbal fluency are the executive 
function components that better predict MCI to dementia conversion in the ACS a year 
later (table 10). These findings are consistent with those from other authors [50-57] who 
supported that category generation should be included in cognitive composites to 
predict cognitive decline. However, a failure in category verbal fluency may be 
indicative of language impairment [55]. Our results have shown that it is the executive 
component which is impaired in fluency tasks insofar as naming and phonemic fluency 
were excluded as predictors of MCI to dementia progression from a regression model 
(Table 12). This result reinforces the idea that executive functions play a key role in 
pathological aging and that they could be an early predictor of dementia in ACS. Our 
recommendation is that to better identify MCI profiles which hold predictive value for 
conversion to dementia in ACS, assessment of categories generation, switching and 
planning abilities must be carried out. 
As MCI converters showed a phenotype that combined dysexecutive and amnestic 
features, corroborating the presence of the latter would remain an essential aim of the 
assessment. As was suggested by other authors [5, 9, 12, 14, 19, 20], a combination of memory 
and executive function tests enables researchers to detect severity of MCI and to predict 
if the person will suffer dementia related with ACS. Our findings further support this 
proposal and suggest that dysexecutive abilities contribute significantly to the risk 
profile of MCI patients.  
Since executive functioning is essential to maintain independence in daily living tasks [5, 
10, 13, 23, 24], we expected impairments when analysing IADL in clusters. As we have 
shown, cluster 3 is the one which is closer to dementia in ACS and with worse 
executive  showed the worst performance in 
IADL tests, such as Lawton & Brody or CDR Sum of boxes (Table 6). These results 
taken together reinforce the idea that is directly 
related with a loss of autonomy in IADL. It is worth noting that dysexecutive 
impairments impacted on IADL and that IADL impairments are a key criterion to 
ascertain conversion from MCI to dementia in ACS. However, in our sample such 
association was independent of the MCI severity, indicating that outcomes from 
cognitive screening tools assessing severity of cognitive decline may not suffice to 
detect risk profiles. A more detailed neuropsychological assessment of executive and 
memory functions will be necessary to identify who may more likely progress to the 
dementia stages regardless of the severity of their cognitive impairments. 
Finally, some limitations of the current study are worth noting. The non-amnestic MCI 
sample was not large enough to enable an exhaustive analysis of each subtype based on 
the traditional classification. This sample size limitation also precluded the possibility 
of investigating phenotypes linked to non-AD or atypical AD variants. Furthermore, as 
our main objective was to identify predictors of risk of conversion to dementia 
seemingly of the Alzheimer´s type, the amnestic subtype was more relevant to such an 
aim. Future research could adopt the phenotyping model proposed here to evaluate 
clinical trajectories of non-amnestic MCI groups. .  
Conclusions 
This study constributes novel evidence on the role of a dysexecutive MCI to predict risk 
of progression to dementia among MCI patients. We have demonstrated that such a 
classification holds higher accuracy to predict dementia a year later than the traditional 
MCI classification. Worse performance on executive function tasks in ma-MCI seems 
to indicate a higher risk of conversion to dementia in the ACS. Executive functions, 
specially switching and category generation, must be evaluated when looking for risk of 
dementia in MCI patients. 
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Tables 
 
Table 1: Baseline and 1 year follow-up clinical and socio-demographic characteristics 
in CU and MCI group 
  
Baseline 1 year follow-up 
CU  
N = 51           
M (SD) 
MCI  
N = 94          
M (SD) 
t Sig. Effect size (cohen-d) 
CU  
N = 36           
M (SD) 
MCI   
N = 72                   
M (SD) 
t Sig. Effect size (cohen-d) 
Age 71.20 (4.50) 74.76 (6.00) -4.03 *** -0.67 71.29 (4.21) 76.07 (6.38) -4.57 *** -0.88 
Education 10.14 (4.97) 8.66 (4.72) 1.77 0.31 10.15 (4.57) 8.24 (4.04) 2.15 * 0.44 
GDS 1.86 (2.55) 2.12 (2.03) -0.66 -0.11 1.44 (1.64) 2.15 (2.21) -1.65 -0.37 
NPI-Q 0.61 (1.15) 1.19 (1.76) -2.31 * -0.39 1.60 (2.05) 1.66 (1.77) -0.15  -0.03 
Lawton & 
Brody 7.91 (0.59) 7.59 (0.89) 2.60 * 0.42 8.00 (0.00) 7.16 (1.47) 4.79 *** 0.81 
CDR total 0.22 (0.27) 0.39 (0.22) -3.65 *** -0.69 0.09 (0.19) 0.41 (0.30) -6.68 *** -1.27 
CDR Sum 
of boxes 6.72 (1.28) 8.78 (2.60) -6.08 *** -1.01 6.52 (1.03) 9.50 (3.52) -6.33 *** -1.15 
MMSE 28.94 (1.36) 27.14 (2.67) 5.38 *** 0.85 28.74 (1.38) 26.34 (3.08) 5.50 *** 1.01 
TAVEC 
STM 10.75 (2.35) 6.12 (3.74) 9.02 *** 1.48 10.49 (3.82) 5.97 (4.29) 5.27 *** 1.11 
TAVEC 
LTM 11.77 (2.02) 6.46 (3.50) 11.44 *** 1.86 11.17 (3.51) 6.50 (4.50) 5.83 *** 1.16 
Rey STM 17.35 (6.05) 11.21 (7.38) 5.26 *** 0.91 18.09 (7.80) 12.19 (7.45) 3.77 *** 0.77 
 
*p<.05,  **p<.005 ***p<.001. STM is used to express Short Term Memory. LTM expresses Long Term 
Memory 
 
  
Table 2: Baseline and 1 year follow-up Z-scores comparation in clinical and socio-
demographic characteristics in CU and MCI group 
  
Baseline vs 1 year follow-up  
CU Z-scores 
Baseline vs 1 year follow-up 
MCI Z-scores 
t Sig. (2-tailed) t Sig. (2-tailed) 
Age 0.74   -0.28   
Education -0.28   0.26   
GDS 0.77   -0.23   
NPI-Q -2.41 * -1.89  
Lawton & Brody -1.43   0.37   
CDR total 0.79   0.18   
CDR Sum of boxes 0.21   0.48   
MMSE -0.49   -0.32   
TAVEC STM 0.79   -0.53   
TAVEC LTM 1.53   -0.93   
Rey STM 0.35   -0.14   
 
*p<.05,  **p<.005 ***p<.001. STM is used to express Short Term Memory. LTM expresses 
Long Term Memory 
 
  
Table 3: Baseline clinical and socio-demographic characteristics of MCI sub-groups 
based on the classical classification 
 
  
Baseline 
CU 
N = 51 
 M (SD) 
aMCI   
N = 26               
M (SD) 
maMCI  
N = 50 
 M (SD) 
naMCI 
N = 18               
M (SD) 
F (3, 
145) Sig. Partial 
ETA2 
Age 71.20 (4.50) 74.73 (4.53) 75.61 (6.46) 72.24 (6.14) 6.29 ***1-2, 1-3 0.12 
Education 10.14 (4.97) 10.04 (4.08) 8.61 (4.87) 6.71 (4.71) 2.75 * 0.05 
GDS 1.86 (2.55) 2.19 (2.53) 2.02 (1.72) 2.29 (2.14) 0.22 0.01 
NPI-Q 0.61 (1.15) 1.27 (2.13) 1.28 (1.63) 0.82 (1.55) 1.69  0.04 
Lawton & 
Brody 7.91 (0.59) 7.58 (0.99) 7.49 (0.95) 7.88 (0.33) 2.77 * 0.04 
CDR 0.22 (0.27) 0.35 (0.24) 0.43 (0.20) 0.34 (0.24) 6.23 **
1-3 0.09 
CDR boxes 6.72 (1.28) 7.68 (2.43) 9.67 (2.60) 7.81 (1.91) 15.07 ***1-3, 2-3, 3-4 0.20 
MMSE 28.94 (1.36) 28.54 (1.27) 26.20 (2.99) 27.77 (2.45) 15.27 ***
1-3, 2-3, 3-4 0.24 
TAVEC 
STM 10.75 (2.35) 6.46 (3.09) 4.63 (3.53) 10.06 (1.98) 41.34 ***
1-2, 1-3, 2-4, 3-4 0.42 
TAVEC 
LTM 11.77 (2.02) 6.46 (2.25) 4.92 (3.15) 11.06 (1.52) 74.40 ***
1-2, 1-3, 2-4, 3-4 0.58 
Rey Copy 33.49 (3.17) 32.08 (3.33) 28.56 (8.21) 30.59 (5.98) 6.12 **1-3 0.13 
Rey STM 17.35 (6.05) 11.73 (6.51) 9.36 (7.28) 15.97 (7.05) 12.89 ***1-2, 1-3, 3-4 0.19 
Rey LTM 17.52 (6.33) 10.62 (6.86) 9.12 (6.74) 15.29 (7.21) 14.47 ***1-2, 1-3, 3-4 0.21 
Boston 11.11 (2.12) 10.85 (2.17) 9.20 (2.74) 9.59 (2.60) 6.01 **1-3, 2-3 0.09 
TMTBA 88.96 (62.90) 87.54 (45.24) 239.06 (159.55) 182.00 (112.82) 18.38 ***1-3, 1-4, 2-3, 2-4 0.25 
FAS 
Phonetics 11.76 (3.20) 11.51 (3.58) 9.24 (4.01) 8.05 (2.43) 7.54 ***
1-3, 1-4, 2-3, 2-4 0.13 
FAS 
Categories 15.16 (2.63) 14.38 (2.29) 11.59 (2.81) 13.63 (2.34) 16.35 ***
1-3, 2-3, 3-4 0.23 
Stroop 52.75 (6.46) 50.42 (8.85) 50.18 (12.41) 44.33 (22.06) 2.02 0.04 
Zoo 1.93 (1.14) 1.50 (1.42) 0.25 (1.21) 0.94 (1.44) 15.19 ***1-3, 1-4, 2-3 0.23 
Similarities 17.02 (4.69) 14.42 (5.29) 14.10 (4.55) 12.71 (3.87) 5.01 **1-3, 1-4 0.08 
Reverse 
Digits 5.27 (1.59) 5.38 (2.00) 4.41 (1.40) 4.18 (1.70) 4.14 * 0.08 
Arithmetics 10.44 (3.73) 9.73 (2.74) 8.41 (3.38) 8.29 (3.20) 3.56 *1-3 0.09 
Letters & 
Numbers 8.20 (2.40) 6.73 (2.41) 5.82 (3.23) 5.12 (2.91) 7.89 ***
1-3, 1-4 0.12 
 
*p<.05, **p<.005, ***p<.001. For Bonferroni analysis: 1= CU, 2= aMCI, 3 = maMCI, 4 = naMCI. STM 
= Short Term Memory, LTM =Long Term Memory 
 
  
Table 4: 1 year follow-up clinical and socio-demographic characteristics of MCI sub-
groups based on the classical classification 
  
1 year follow-up 
CU                 
M (SD) 
aMCI                    
M (SD) 
maMCI                  
M (SD) 
naMCI               
M (SD) 
F (3, 
104) Sig. Partial 
ETA2 
Age 71.29 (4.20) 75.28 (4.76) 77.39 (6.74) 73.31 (6.60) 7.41 ***1-3 0.18 
Education 10.15 (4.57) 9.72 (3.86) 7.92 (4.33) 7.08 (2.96) 2.71 * 0.06 
GDS 1.44 (1.64) 1.89 (2.35) 2.27 (2.26) 2.15 (1.99) 1.03 0.01 
NPI-Q 1.83 (2.39) 1.81 (2.04) 1.82 (1.67) 1.23 (1.15) 0.64  0.03 
Lawton & 
Brody 8.00 (0.00) 7.00 (1.68) 6.95 (1.56) 7.93 (0.27) 6.55 ***
1-2, 1-3 0.10 
CDR 0.09 (0.19) 0.33 (0.30) 0.46 (0.29) 0.36 (0.31) 12.49 ***
1-2, 1-3, 1-4 0.23 
CDR boxes 6.52 (1.03) 8.67 (3.52) 10.16 (3.59) 8.54 (3.13) 8.79 ***1-3 0.16 
MMSE 28.74 (1.38) 27.78 (1.96) 25.50 (3.30) 26.79 (3.04) 10.36 ***
1-3, 2-3 0.19 
TAVEC STM 10.49 (3.82) 6.78 (3.72) 4.13 (3.92) 9.93 (2.84) 20.01 ***1-2, 1-3, 3-4 0.33 
TAVEC LTM 11.17 (3.51) 6.50 (4.00) 4.82 (4.11) 11.07 (2.76) 21.62 ***
1-2, 1-3, 2-4, 3-4 0.33 
Rey Copy 33.43 (3.03) 31.58 (3.75) 27.34 (9.25) 30.64 (4.81) 5.87 **1-3 0.12 
Rey STM 18.09 (7.80) 14.61 (5.15) 9.07 (7.14) 17.54 (6.87) 11.33 ***
1-3, 2-3, 3-4 0.25 
Rey LTM 18.30 (7.19) 14.58 (4.15) 9.01 (6.29) 16.21 (6.53) 13.79 ***1-3, 2-3, 3-4 0.27 
Boston 11.34 (2.41) 11.11 (1.81) 8.92 (2.84) 10.43 (2.31) 6.63 ***
1-3, 2-3 0.12 
TMTBA 81.14 (59.47) 99.61 (114.09) 
198.84 
(158.47) 
177.79 
(77.80) 7.54 ***
1-3, 2-3 0.15 
FAS Phonetics 12.29 (3.66) 11.71 (3.67) 8.71 (4.11) 8.28 (3.26) 7.62 ***1-3, 1-4, 2-3 0.15 
FAS 
Categories 15.69 (2.62) 14.37 (1.92) 11.16 (3.43) 14.04 (2.94) 15.61 ***
1-3, 2-3, 3-4 0.22 
Stroop 52.43 (11.53) 49.44 (14.98) 49.14 (11.40) 48.50 (24.90) 0.43 0.01 
Zoo 1.14 (1.12) 0.67 (1.33) 0.22 (1.36) 1.14 (1.88) 3.29 *1-3 0.09 
Similarities 18.71 (5.13) 15.94 (3.93) 13.03 (4.74) 14.64 (4.70) 8.96 ***1-3, 1-4 0.16 
Reverse Digits 5.43 (1.46) 5.06 (1.66) 4.16 (1.82) 4.07 (1.64) 4.55 *1-3 0.10 
Arithmetics 8.71 (3.11) 9.50 (4.13) 7.76 (3.09) 6.64 (2.53) 2.58 0.08 
Letters & 
Numbers 8.06 (2.33) 7.56 (2.92) 5.00 (3.09) 5.00 (2.83) 9.49 ***
1-3, 1-4, 2-3 0.17 
 
*p<.05, **p<,005,***p<.001. For Bonferroni analysis: 1= CU, 2= aMCI, 3 = maMCI, 4 = naMCI. STM = 
Short Term Memory, LTM =Long Term Memory 
 
 
  
 
Table 5: Baseline and 1 year follow-up clinical and socio-demographic characteristics 
comparation among MCI traditional sub-groups and controls 
  
Baseline 1 year follow-up 
CU VS aMCI    
Zscore 
CU VS maMCI 
Zscore 
CU VS naMCI 
Zscore 
CU VS aMCI    
Zscore 
CU VS maMCI 
Zscore 
CU VS naMCI 
Zscore 
t Sig. (2-tailed) t 
Sig. (2-
tailed) t 
Sig. (2-
tailed) t 
Sig. (2-
tailed) t 
Sig. (2-
tailed) t 
Sig. (2-
tailed) 
Age -3.25 ** -4.00 *** -.75 -3.13 ** -4.68 *** -1.03   
Education 0.09 1.57   2.50 * 0.34 2.10 * 2.24 * 
GDS -0.54 -0.37   -.63 -0.81 -1.76   -1.26   
NPI-Q -1.45  -2.31 * -0.58  -0.11  0.47  -1.03  
Lawton & 
Brody 1.58  2.67 * .20  2.53 * 4.16 *** 1.00   
CDR -2.01 * -4.23 *** -1.58 -3.21 ** -6.40 *** -3.09 * 
CDR boxes -1.83 -6.98 *** -2.12 * -2.32 * -5.96 *** -2.28 * 
MMSE 1.25 5.97 *** 2.03 2.09 * 5.55 *** 2.31 * 
TAVEC 
STM 6.70 *** 10.22 *** 1.08  3.37 ** 7.00 *** 0.49   
TAVEC 
LTM 10.36 *** 12.95 *** 1.32  4.37 *** 7.07 *** 0.10   
Rey Copy 1.79 3.98 *** 1.91 1.93 3.84 *** 2.01   
Rey STM 3.70 *** 5.88 *** .77 1.70 5.16 *** 0.23   
Rey LTM 4.31 *** 6.31 *** 1.19 2.38 * 5.88 *** 0.94   
Boston 0.50 3.86 *** 2.37 * 0.36 3.91 *** 1.21   
TMTBA 0.10 -6.21 *** -3.22 ** -0.64 -4.26 *** -4.70 *** 
FAS 
Phonetics 0.30  3.39 ** 4.34 *** 0.55  3.92 *** 3.57 ** 
FAS 
Categories 1.27  6.46 *** 2.11 * 1.88  6.29 *** 1.92   
Stroop 1.17 1.29   1.55 0.81 1.23   0.76   
Zoo 1.41 6.97 *** 2.85 * 1.38 3.16 ** 0.00   
Similarities 2.16 * 3.11 ** 3.39 ** 2.00 4.92 *** 2.57 * 
Reverse 
Digits -0.27  2.80 * 2.37 * 0.84  3.27 ** 2.84 * 
Arithmetics 0.85 2.80 * 2.10 * -0.78 1.31   2.21 * 
Letters & 
Numbers 2.48 * 4.13 *** 4.26 *** 0.68   4.74 *** 3.91 *** 
 
*p<.05, **p<,005,***p<.001. STM = Short Term Memory, LTM =Long Term Memory 
 
  
Table 6: C
from CU and the three MCI clusters 
 
  
CU 
N = 51 
M (SD) 
Cluster 1  
N = 56            
M (SD) 
Cluster 2 
N = 28             
M (SD) 
Cluster 3 
N = 10               
M (SD) 
F (3, 140) Sig. Partial ETA2 
Age 71.20 (4.50) 73.59 (6.02) 76.00 (5.52) 77.80 (5.92) 7.16 ***0-2, 0-3 0.13 
Education 10.14 (4.97) 9.46 (4.91) 7.61 (4.56) 7.10 (3.28) 1.78 0.04 
GDS 1.86 (2.55) 2.18 (2.19) 2.04 (1.86) 2.00 (1.63) 0.33 0.01 
NPI-Q 0.61 (1.15) 1.38 (2.01) 0.67 (1.04) 1.60 (1.58) 2.83 * 0.06 
Lawton & 
Brody 7.91 (0.59) 7.77 (0.71) 7.54 (0.96) 6.70 (1.06) 5.88 **
0-3, 1-3, 2-3 0.12 
CDR 0.22 (0.27) 0.36 (0.23) 0.43 (0.23) 0.50 (0.00) 4.78 **0-1, 0-2, 0-3 0.10 
CDR boxes 6.72 (1.28) 7.98 (2.30) 9.27 (2.68) 11.70 (1.34) 14.19 ***
0-1, 0-2, 0-3, 1-3, 2-3 0.25 
MMSE 28.94 (1.36) 27.82 (1.93) 26.43 (3.23) 25.30 (3.40) 12.40 ***0-2, 0-3, 1-2, 1-3 0.21 
TAVEC 
STM 10.75 (2.35) 6.61 (3.15) 6.61 (4.32) 2.00 (2.67) 22.80 ***
0-1, 0-2, 0-3, 1-3, 2-3 0.33 
TAVEC 
LTM 11.77 (2.02) 6.73 (3.03) 7.18 (3.95) 2.90 (2.73) 33.41 ***
0-1, 0-2, 0-3, 1-3, 2-3 0.42 
Rey Copy 33.49 (3.17) 30.69 (6.15) 29.14 (7.34) 27.60 (9.46) 5.62 **0-2, 0-3 0.11 
Rey STM 17.35 (6.05) 12.29 (7.08) 11.57 (7.75) 4.20 (3.82) 10.24 ***
0-1, 0-2, 0-3, 1-3, 2-3 0.18 
Rey LTM 17.52 (6.33) 11.90 (6.92) 10.61 (7.47) 3.80 (2.71) 12.44 ***0-1, 0-2, 0-3, 1-3, 2-3 0.22 
Boston 11.11 (2.12) 10.32 (2.54) 9.36 (2.47) 7.40 (2.37) 6.06 **
0-2, 0-3, 1-3 0.12 
TMTBA 88.96 (62.90) 
89.50 
(45.33) 
290.86 
(79.34) 
440.60 
(134.60) 111.08 ***
0-2, 0-3, 1-2, 1-3, 2-3 0.71 
FAS 
Phonetics 11.76 (3.20) 10.66 (3.59) 8.75 (3.68) 6.57 (3.52) 7.83 ***
0-2, 0-3, 1-3 0.15 
FAS 
Categories 15.16 (2.63) 13.20 (2.66) 12.94 (2.71) 9.48 (2.58) 11.05 ***
0-1, 0-2, 0-3, 1-3, 2-3 0.20 
Stroop 52.75 (6.46) 
49.81 
(12.01) 47.81(18.57) 49.60 (8.30) 0.49  0.01 
Zoo 1.93 (1.14) 1.04 (1.35) 0.64 (1.37) -0.80 (0.79) 14.12 ***0-1, 0-2, 0-3, 1-3, 2-3 0.24 
Similarities 17.02 (4.69) 14.63 (4.74) 13.61 (4.52) 11.00 (3.43) 5.30 **0-2, 0-3 0.11 
Reverse 
Digits 5.27 (1.59) 5.04 (1.78) 4.14 (1.48) 3.80 (1.03) 4.47 *
0-2 0.09 
Arithmetics 10.44 (3.73) 9.16 (3.18) 8.54 (3.49) 7.10 (1.85) 4.78 **0-3 0.10 
Letters & 
Numbers 8.20 (2.40) 6.82 (2.81) 4.89 (2.95) 4.00 (2.36) 10.09 ***
0-2, 0-3, 1-2, 1-3 0.18 
 
*p<.05, **p<.005, ***p<.001. For Bonferroni analysis: 0 = CU, 1 = Cluster 1, 2 = Cluster 2 and 3 = 
Cluster 3. STM = Short Term Memory, LTM = Long Term Memory 
 
 
  
 
Table 7: C
comparation among CU and clusters 
  
CU VS Cluster 1 Zscore CU VS Cluster 2 Zscore CU VS Cluster 3 Zscore 
t Sig. (2-tailed) t Sig. (2-tailed) t Sig. (2-tailed) 
Age -2.34 * -4.18 *** -4.03 *** 
Education 0.70 2.23 * 2.43 * 
GDS -0.69 -0.32   -0.17   
NPI-Q -2.38 * -0.20  -2.29 * 
Lawton & Brody 1.13 1.87   3.50 * 
CDR -2.65 * -3.40 ** -6.83 *** 
CDR boxes -3.39 ** -4.55 *** -11.00 *** 
MMSE 3.49 ** 3.93 *** 3.33 * 
TAVEC STM 7.67 *** 4.68 *** 10.48 *** 
TAVEC LTM 9.80 *** 5.72 *** 11.86 *** 
Rey Copy 2.97 ** 2.97 * 1.95   
Rey STM 3.86 *** 3.60 ** 8.79 *** 
Rey LTM 4.24 *** 4.25 *** 10.83 *** 
Boston 1.67 3.24 ** 4.91 *** 
TMTBA -0.05 -12.12 *** -8.07 *** 
FAS Phonetics 1.62 3.71 *** 4.58 *** 
FAS Categories 3.72 *** 3.48 ** 6.22 *** 
Stroop 1.57 1.36   1.32   
Zoo 3.63 *** 4.36 *** 7.21 *** 
Similarities 2.56 * 3.08 ** 3.83 *** 
Reverse Digits 0.68 3.02 ** 2.78 * 
Arithmetics 1.86 2.18 * 2.74 * 
Letters & Numbers 2.62 * 5.26 *** 5.02 *** 
 
*p<.05, **p<,005,***p<.001. STM = Short Term Memory, LTM =Long Term Memory 
 
  
Table 8: Distribution of participants that progress to dementia in ACS a year later 
MCI Clusters 
  a ma na 1 2 3 
N 22 48 15 57 28 10 
Conversion 0 10 0 0 0 10 
% 0 20.83% 0 0 0 100% 
 
  
Table 9: Baseline assessment of executive functions of converter and stable MCI 
 
Converter 
N = 10 
M (SD) 
Stable 
N = 62                   
M (SD) 
t Sig. Effect size (Cohen-d) 
Age 77.80 (5.92) 74.47 (6.30) -1.561 0.545 
Education 7.10 (3.28) 8.62 (5.11) .905 -0.354 
GDS 2.00 (1.63) 2.07 (1.84) .108 -0.04 
NPI-Q 1.60 (1.58) 1.08 (1.70) -0.90  0.32 
Lawton & Brody 6.70 (1.06) 7.72 (0.72) 2.926 * -1.126 
CDR 0.50 (0.00) 0.40 (0.20) -3.848 *** 0.707 
CDR boxes 11.70 (1.34) 8.54 (2.50) -5.870 *** 1.576 
MMSE 25.30 (3.40) 27.33 (2.50) 2.256 * -0.68 
TAVEC STM 2.00 (2.67) 6.83 (3.43) 4.237 *** -1.571 
TAVEC LTM 2.90 (2.73) 7.37 (3.18) 4.182 *** -1.508 
Rey Copy 27.60 (9.46) 30.68 (5.95) 1.384 -0.39 
Rey STM 4.20 (3.82) 12.21 (7.19) 3.426 ** -1.391 
Rey LTM 3.80 (2.71) 11.76 (6.78) 6.498 *** -1.542 
Boston 7.40 (2.37) 10.03 (2.44) 3.170 ** -1.093 
TMTBA 440.60 (134.60) 159.50 (116.11) -6.932 *** 2.236 
FAS Phonetics 6.57 (3.52) 9.94 (3.71) 2.676 * -0.932 
FAS Categories 9.48 (2.58) 13.06 (2.60) 4.042 *** -1.382 
Stroop 49.60 (8.30) 49.44 (13.42) -.036 0.014 
Zoo (-)0.80 (0.79) 0.82 (1.36) 3.646 ** -1.457 
Similarities 11.00 (3.43) 14.52 (4.92) 2.167 * -0.83 
Reverse Digits 3.80 (1.03) 4.67 (1.61) 1.639 -0.644 
Arithmetics 7.10 (1.85) 9.12 (3.44) 1.803 -0.731 
Letters & Numbers 4.00 (2.36) 6.27 (3.04) 2.246 * -0.834 
*p<.05,  **p<.005 ***p<.001. STM = Short Term Memory, LTM = Long Term Memory 
 
  
Tabla 10: Simple (top-row) and stepwise (bottom row) linear 
regression models including executive function components. 
  F Sig. R2 
TMTB-A 48.052 0.000 .414 
TMTB-A + Fluency Semantic Categories 27.489 0.000 .451 
 
 
  
Table 11: Simple (top-row) and stepwise (bottom 
row) linear regression models including classical 
(memory-based) MCI and dysexecutive MCI. 
  F Sig. R2 
Classical MCI 0.082 0.776 0.001 
Dysexecutive MCI 41.917 0.000 0.381 
Classical MCI + MMSE 5.090 0.955 0,070 
Dysexecutive MCI + MMSE 116.251 0.000 0.631 
 
  
 Table 12: Stepwise (bottom row) linear regression model including 
dysexecutive MCI classification and category fluency test. 
F Sig. R2 
Dysexecutive MCI 116.251 0.000 0.631 
Dysexecutive MCI + Category Fluency 62.934 0.000 0.653 
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